Financials
Financial year 2025
Dr. Haverbeke Chloë, ONCOLOGIE from Kortrijk, company number BE0678361382, closed financial year 2025 with a result of € 89,979 after tax. For that financial year Dr. Haverbeke Chloë, ONCOLOGIE recorded a gross margin of € 119,644 and equity of € 28,098. Compared with financial year 2024, the result moved from € 84,579 to € 89,979. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 28,098
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 89,979
▲ 6% vs 2024
Profit after tax over the fiscal year.
€ 105,290
▼ 1% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 90,000 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,174
▲ 104% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,500
▼ 3% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 98,740 | € 101,503 | € 117,980 | € 119,644 | ▲ 1% |
| Profit after taxes | € 68,917 | € 72,063 | € 84,579 | € 89,979 | ▲ 6% |
| Equity | € 96,477 | € 38,540 | € 28,119 | € 28,098 | |
| Total debts | € 7,154 | € 65,021 | € 100,684 | € 98,525 | ▼ 2% |
| Cash | € 63,485 | € 72,351 | € 106,510 | € 105,290 | ▼ 1% |
| Retained profit | € 77,877 | € 19,940 | € 9,519 | € 9,498 | |
| Dividend | € 130,000 | € 130,000 | € 95,000 | € 90,000 | ▼ 5% |
| Bank debt | € 5,487 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 103,631 | € 103,561 | € 128,803 | € 126,623 | ▼ 2% |
Key figures of Dr. Haverbeke Chloë, ONCOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr. Haverbeke Chloë, ONCOLOGIE?
What happened at Dr. Haverbeke Chloë, ONCOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 89,979 (▲ 6% vs 2024). Source: NBB ↗
- New establishment in Kortrijk. KBO
- Start of the company according to the CBE. KBO
In short
From € 68,917 profit in 2022 to € 89,979 profit in 2025.
Paid € 89,400 in corporate taxes since 2022.
Best year ever: 2025, with € 89,979 profit.
Paid out € 445,000 in dividends to the owners in total.
A new publication or filing at Dr. Haverbeke Chloë, ONCOLOGIE? We notify you, reason included.
Follow Dr. Haverbeke Chloë, ONCOLOGIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr. Haverbeke Chloë, ONCOLOGIE is Chloë HAVERBEKE.
Directors
According to the 2025 annual accounts
Chloë HAVERBEKE
Director
Establishments
Establishment units
Physical locations of this company
Marionetten(Kor) 38
8500 Kortrijk
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0678.361.382
- VAT number
- BE 0678.361.382
- Registered office
- Marionetten(Kor) 38, 8500 Kortrijk
- Names & denominations
- Dr. Haverbeke Chloë, ONCOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 6 July 2017
- Peppol
- Active · Active since 2 Oct 2025
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten op het gebied van voeding
Overige vormen van onderwijs
Overige menselijke gezondheidszorg, n.e.g.